All Access

Pro Rata Premium

Axios Pro Rata Premium

Standard

Axios Pro Rata: Non-Premium Subscribers

Other

The latest FDA appointment gave us all a lot to think about this week. More below...

👁️ Lenz Therapeutics inks $125M licensing deal with Lotus

💊 Biotech Alchemab lands $415M licensing deal with Eli Lilly

😬 Biotech investing "has never been as bad as this"

💸 Deerfield Management raises $600M fund in "constrained" market

Lenz Therapeutics inks $125M licensing deal with Lotus

Biotech Alchemab lands $415M licensing deal with Eli Lilly

Biotech investing "has never been as bad as this"

Deerfield Management raises $600M fund in "constrained" market

The week that was

https://images.axios.com/d9qP9pasxWxoLBGkVy04bp5DVm8=/filters:no_upscale()/2025/05/09/1746807763009.gif

Animated illustration of a pill with an Rx prescription symbol embossed onto it that changes into a percent sign.

The latest <a class="gtmContentClick" data-vars-link-text="FDA appointment" data-vars-click-url="https://www.axios.com/2025/05/06/rfk-jr-new-top-vaccine-regulator" data-vars-content-id="5a18121b-33a1-47bf-8be2-f17cd5683193" data-vars-headline="The week that was" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/2025/05/06/rfk-jr-new-top-vaccine-regulator" target="_self">FDA appointment</a> gave us all a lot to think about this week. More below...👁️ <a class="gtmContentClick" data-vars-link-text="Lenz Therapeutics inks $125M licensing deal with Lotus" data-vars-click-url="https://www.axios.com/pro/biotech-deals/2025/05/09/lenz-therapeutics-inks-125m-licensing-deal-with-lotus" data-vars-content-id="5a18121b-33a1-47bf-8be2-f17cd5683193" data-vars-headline="The week that was" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/pro/biotech-deals/2025/05/09/lenz-therapeutics-inks-125m-licensing-deal-with-lotus" target="_self">Lenz Therapeutics inks $125M licensing deal with Lotus</a>🆘 <a class="gtmContentClick" data-vars-link-text="Biotech bucks blockade" data-vars-click-url="https://www.axios.com/newsletters/axios-pro-rata-d363b2f9-9f57-448b-9fb0-25a74d7b9859.html?chunk=1&amp;utm_term=twsocialshare#story1 #axiosprorata " data-vars-content-id="5a18121b-33a1-47bf-8be2-f17cd5683193" data-vars-headline="The week that was" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/newsletters/axios-pro-rata-d363b2f9-9f57-448b-9fb0-25a74d7b9859.html?chunk=1&amp;utm_term=twsocialshare#story1 #axiosprorata " target="_self">Biotech bucks blockade</a>💊 <a class="gtmContentClick" data-vars-link-text="Biotech Alchemab lands $415M licensing deal with Eli Lilly" data-vars-click-url="https://www.axios.com/pro/biotech-deals/2025/05/06/biotech-alchemab-lands-415m-licensing-deal-with-eli-lilly" data-vars-content-id="5a18121b-33a1-47bf-8be2-f17cd5683193" data-vars-headline="The week that was" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/pro/biotech-deals/2025/05/06/biotech-alchemab-lands-415m-licensing-deal-with-eli-lilly" target="_self">Biotech Alchemab lands $415M licensing deal with Eli Lilly</a>😬 <a class="gtmContentClick" data-vars-link-text="Biotech investing &quot;has never been as bad as this&quot;" data-vars-click-url="https://www.axios.com/pro/health-tech-deals/2025/05/05/biotech-investing-milken-panelists" data-vars-content-id="5a18121b-33a1-47bf-8be2-f17cd5683193" data-vars-headline="The week that was" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/pro/health-tech-deals/2025/05/05/biotech-investing-milken-panelists" target="_self">Biotech investing &quot;has never been as bad as this&quot;</a>💸 <a class="gtmContentClick" data-vars-link-text="Deerfield Management raises $600M fund in &quot;constrained&quot; market" data-vars-click-url="https://www.axios.com/pro/biotech-deals/2025/05/05/deerfield-management-raises-600m-fund-in-constrained-market" data-vars-content-id="5a18121b-33a1-47bf-8be2-f17cd5683193" data-vars-headline="The week that was" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/pro/biotech-deals/2025/05/05/deerfield-management-raises-600m-fund-in-constrained-market" target="_self">Deerfield Management raises $600M fund in &quot;constrained&quot; market</a>

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

transportation

business

c-suite

retail-news

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

salt-lake-city

denver

fort-lauderdale

boulder

kansas-city

austin

chicago

dallas

detroit

washington-dc

atlanta

indianapolis

nashville

nw-arkansas

columbus

hollywood

richmond

san-francisco

boston

des-moines

houston

phoenix

miami

philadelphia

seattle

new-orleans

colorado-springs

huntsville

raleigh

san-antonio

twin-cities

pittsburgh

arapahoe

douglas

san-diego

tampa-bay

portland

cleveland

axios-local

axios-pro

axios-live

the-axios-show

The week that was

What to read next